Flower

Low cost vaccine to be manufactured

by The Welthi Bureau | 10 JAN 2017

low cost vaccine to be manufactured
 Image used for representational purpose only

Hilleman Laboratories to collaborate with Imperial College London, Engineering and Physical Sciences Research Council (UK) and other premier international bodies towards low-cost vaccine manufacturing

 

 

Hilleman Laboratories, an equal joint-venture partnership between MSD and Wellcome Trust, is honored to be one of the key partners of the new Future Vaccine Manufacturing Hub led by Imperial College London. The hub has been established to increase immunisation coverage across the globe and improve the response to disease outbreaks through the rapid and cost-effective deployment of vaccines. £10 million of funding has been granted by the UK Department for Health, and will be managed by the Engineering and Physical Sciences Research Council (EPSRC).   

 

 

The all-new Future Vaccine Manufacturing Hub aims to address two major challenges facing creation of future vaccine manufacturing systems:   

 

 

How to design vaccine production systems that can produce tens of thousands of new doses within weeks of a new threat being identified

 

 

How to improve current manufacturing processes and change the way vaccines are manufactured, stabilized and stored so that existing and new diseases can be prevented effectively, at reduced costs      

 

 

Speaking on the occasion, Dr Davinder Gill, CEO Hilleman Laboratories said, “We are honored to collaborate with Imperial College London and EPSRC in the United Kingdom. We are gratified with this collaboration, which will help us develop our competences through international partnerships. As a partner in manufacturing research projects, we are truly hoping that the new Vaccine Manufacturing Hub will increase immunisation coverage around the globe and respond to disease outbreaks with safe and cost-effective vaccines. It will allow us to invest in innovation more effectively to explore high-quality vaccines & technologies.”    

 

 

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India, Vietnam, Bangladesh, Uganda and China. Integrated approaches that will be explored by researchers at the Hub include the development of synthetic RNA vaccines which can be rapidly manufactured; the rapid production of yeast and bacterially-expressed particles that mimic components of pathogenic viruses and bacteria; and protein stabilisation to preserve vaccines at high temperatures, avoiding the need for refrigerated distribution and storage.  

 

 

The Hub is led by Imperial College London, and also involves the Universities of Bristol, Cambridge and Nottingham, Cranfield University, the Clinical Biotechnology Centre (CBC) as part of NHS Blood and Transplant, UK National Biologics Manufacturing Centre, CPI and National Institute for Biological Standards and Control (NIBSC). The hub will also collaborate with the Developing Countries Vaccine Manufacturing Network (DCVMN) and African Vaccine Manufacturers Initiative (AVMI) to maximise dissemination of knowledge.


 Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person. Read more
A COMPLETE SKIN CARE REGIMEN FOR HOLI

A COMPLETE SKIN CARE REGIMEN FOR HOLI

The festival of Holi augments fun, frolic, and hap...
HOLISTIC DENTISTRY

HOLISTIC DENTISTRY

HOLISTIC DENTISTRY...
Remarkable improvement in 10 year Old Rayneesha suffering from Cerebral Palsy

Remarkable improvement in 10 year Old Rayneesha ...

When Rayneesha was born, the doctors at her hometo...
NOW RURAL INDIA CAN GET TREATED FOR DIABETES AT THEIR DOORSTEP

NOW RURAL INDIA CAN GET TREATED FOR DIABETES AT ...

the non-physician health workers would generate el...
ANGINA (CHEST PAIN) COULD BE A WARNING SIGN OF AN UNDERLYING CARDIOVASCULAR DISEASE

ANGINA (CHEST PAIN) COULD BE A WARNING SIGN OF ...

Angina is experienced as pain in the centre of the...
HIGH FREQUENCY ULTRASOUND IS THE FUTURE OF NEUROSURGERY   KIMS Hospitals Secunderabad demonstrates Live Neurosurgery Procedure

HIGH FREQUENCY ULTRASOUND IS THE FUTURE OF ...

Neurosurgeons are using Laser technology where the...
World Stroke Day 29th Oct 2018

World Stroke Day 29th Oct 2018

A stroke is defined as an abrupt onset of a neurol...
Hyderabad Doctors successfully perform Asia's First Transcatheter Tricuspid Valve Replacement procedure

Hyderabad Doctors successfully perform Asia's ...

Only 40 such surgeries reported around the world...
SuVitas Launches Bangalore’s First Dedicated Transition Care Facility

SuVitas Launches Bangalore’s First Dedicated ...

Catering to a need for post critical care that has...
Itermittent Fasting: The How s and Why's

Itermittent Fasting: The How s and Why's

Intermittent Fasting is the latest global fitness ...
Our responsibility to our emotions

Our responsibility to our emotions

In this world, there are all kinds of people. Some...
Eyes show you the world

Eyes show you the world

With increasing rate of air pollution, the ways it...